Skip to main content
Caplight Logo









CLADE

CLADE

Private
GermanyHealthcare & Life Scienceshttps://clade.io

Last Round

Series A

Jan 30, 2024

Total Funding Raised

$15.7M

Company Overview

CLADE operates in Healthcare & Life Sciences and is based in Germany. Its latest recorded funding round was a Series A round in January 2024.

CLADE is a life sciences company that develops mid-infrared (MIR) spectroscopy solutions and analytical software for biopharmaceutical quality control and process monitoring.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Sensors

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

CLADE Comparables

Compare CLADE with similar companies based on industry and business-model similarity.

CLADE comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
IRUBIS
81%
Nirrin Technologies
76%
Timegate Instruments
75%
Book a demo to see all comparables

For institutional investors. Book with your work email.

CLADE Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 30, 2024
SeedJan 16, 2018
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Dominik Sievert

CEO

Executive Team

Rainer Marquart

CEO

Executive Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 23, 2026

    Grew 24% QoQ, from 66 to 82 employees.

  • Feb 1, 2026

    Monthly visitors increased 89% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

CLADE Filings

Explore SEC and related filing metadata, where available.

CLADE filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about CLADE's valuation, stock price, and market status.

Is CLADE a public or private company?

CLADE is a private company.

What is the current stock price of CLADE?

CLADE is a private company, so its shares have no public market price. Caplight tracks CLADE's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is CLADE worth (valuation)?

Valuation information for CLADE is not publicly available.

Can I buy CLADE stock?

CLADE shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was CLADE's last funding round?

CLADE's most recent funding round was Series A on January 30, 2024.

Who are the main investors in CLADE?

Investor information for CLADE is not publicly disclosed.

Will CLADE IPO soon?

No public IPO plans have been announced for CLADE.

How can I track CLADE secondary market activity?

Caplight tracks bids, offers, and trades in CLADE's shares on secondary markets.

Firmographic Details

HeadquartersGermany
Employee Range82
Year Founded2001
Last FundingJan 30, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?